The strong Q2 beat and cash generation are overshadowed by the withdrawal of Q3 guidance due to a regulatory cliff on November 12, 2026. Traders should monitor legislative developments regarding the federal hemp-derived THC ban; a favorable resolution could unlock significant upside, while an unfavorable one could severely impair the business.
Price Chart
Executive Summary
RYTHM reported Q2 2026 revenue of $23.0M, up 73% sequentially from $13.3M, and net income of $1.2M vs a loss of $7.4M a year ago. Adjusted EBITDA swung to $6.4M from breakeven. However, the company withdrew Q3 guidance due to regulatory uncertainty from a pending federal ban on hemp-derived THC products effective November 12, 2026, creating significant downside risk despite strong operational momentum.
Key Financial Metrics
Key Facts
- Revenue from continuing operations of $23.0M, up 73% from $13.3M in the prior quarter.
- Net income of $1.2M compared to a net loss of $7.4M in Q2 2025.
- Adjusted EBITDA of $6.4M vs approximately breakeven in the prior quarter.
- Cash increased to $41.9M, driven by cash flow from operations of $8.7M.
- THC beverage depletions reached a record ~25,000 cases in June 2026, up from ~7,000 in June 2025.
- Company withdrew Q3 2026 outlook due to uncertainty from pending federal law changes affecting hemp-derived THC products effective November 12, 2026.
- Fixed annual cash licensing fees of $70M from Green Thumb Industries took effect April 1, 2026.
Financial Impact
Revenue of $23.0M, net income of $1.2M, Adjusted EBITDA of $6.4M, cash of $41.9M
Risk Factors
- Pending federal ban on hemp-derived THC products effective November 12, 2026, creating extreme regulatory uncertainty.
- Withdrawn Q3 guidance signals lack of near-term visibility.
- High share dilution potential from 11.0M warrants and 3.0M convertible note shares outstanding vs 2.2M basic shares.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3338135 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $17.16 | awaiting T+20 | — | $16.05 (−6.47%) |
Aug 11, 2026 11w ago | 8-K | $20.95 $23.64 | ▼ −12.84% | ▼ −13.90% | $16.05 (+23.39%) |
Aug 4, 2026 12w ago | Press Release | $25.44 $22.64 | ▼ −11.01% | ▼ −9.77% | $16.05 (−36.91%) |
Jun 18, 2026 18w ago | 8-K | $27.98 $22.75 | ▼ −18.69% | ▼ −19.22% | $16.05 (−42.64%) |
Jun 10, 2026 19w ago | 144 | $27.56 $21.71 | ▼ −21.23% | ▼ −24.85% | $16.05 (−41.76%) |
May 8, 2026 24w ago | Press Release | $26.19 $25.30 | ▼ −3.40% | ▼ −3.42% | $16.05 (−38.72%) |
Apr 27, 2026 26w ago | DEFA14A | $31.90 $26.80 | ▼ −15.99% | ▼ −20.94% | $16.05 (−49.69%) |
Mar 3, 2026 33w ago | Press Release | $17.45 $30.00 | ▲ +71.92% | ▲ +76.34% | $16.05 (−8.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers